Genetic polymorphism and interethnic variability of plasma paroxonase activity
- PMID: 1003443
- PMCID: PMC1013436
- DOI: 10.1136/jmg.13.5.337
Genetic polymorphism and interethnic variability of plasma paroxonase activity
Abstract
A method for determining plasma paroxonase activity using an auto-analyser is described. Frequency distributions for British and Indian subjects show bimodality. A study of 40 British families confirms the presence of a genetic polymorphism with regard to plasma paroxonase activity. Two phenotypes can be defined, controlled by two alleles at one autosomal locus. The frequency of the low activity phenotype is less in the Indian population than in the British population. Malay, Chinese, and African subjects fail to show obvious bimodality.
Similar articles
-
Plasma paroxonase activity in old age.Age Ageing. 1977 May;6(2):89-95. doi: 10.1093/ageing/6.2.89. Age Ageing. 1977. PMID: 888750
-
EsD in Negro and Caucasian populations: is the EsD5 a 'Caucasian allele'?Hum Hered. 1986;36(3):154-7. doi: 10.1159/000153619. Hum Hered. 1986. PMID: 3721518
-
Activity of esterases in plasma from Ghanaian and British subjects.Eur J Clin Pharmacol. 1986;31(4):485-9. doi: 10.1007/BF00613529. Eur J Clin Pharmacol. 1986. PMID: 3028817
-
Blood polymorphisms and racial admixture in two Brazilian populations.Am J Phys Anthropol. 1982 Jun;58(2):127-32. doi: 10.1002/ajpa.1330580204. Am J Phys Anthropol. 1982. PMID: 7114199
-
Interethnic differences of PEPT2 (SLC15A2) polymorphism distribution and associations with cephalexin pharmacokinetics in healthy Asian subjects.Eur J Clin Pharmacol. 2009 Jan;65(1):65-70. doi: 10.1007/s00228-008-0488-4. Epub 2008 Sep 3. Eur J Clin Pharmacol. 2009. PMID: 18766334 Clinical Trial.
Cited by
-
A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease.J Clin Invest. 1995 Dec;96(6):3005-8. doi: 10.1172/JCI118373. J Clin Invest. 1995. PMID: 8675673 Free PMC article.
-
Clinical significance of esterases in man.Clin Pharmacokinet. 1985 Sep-Oct;10(5):392-403. doi: 10.2165/00003088-198510050-00002. Clin Pharmacokinet. 1985. PMID: 3899454 Review.
-
Pharmacogenetics of paraoxonases: a brief review.Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):78-88. doi: 10.1007/s00210-003-0833-1. Epub 2003 Oct 25. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 14579013 Review.
-
Paraoxonase 1 (PON1) promoter (-107T/C) and coding region (192Q/R and 55L/M) genetic variations in pseudoexfoliation syndrome and pseudoexfoliative glaucoma risk.Graefes Arch Clin Exp Ophthalmol. 2019 Oct;257(10):2257-2270. doi: 10.1007/s00417-019-04408-w. Epub 2019 Jul 10. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 31292763
-
Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model.J Clin Invest. 1996 Apr 1;97(7):1630-9. doi: 10.1172/JCI118589. J Clin Invest. 1996. PMID: 8601628 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources